Leihong Xiang Selected Research

Leihong Xiang Research Topics

Disease

8	Vitiligo 01/2022 - 12/2011
6	Hyperpigmentation 07/2022 - 09/2015
6	Acne Vulgaris 01/2022 - 08/2012
3	Melanoma (Melanoma, Malignant) 10/2021 - 01/2003
2	Melanosis (Freckles) 01/2022 - 12/2020
2	Inflammation (Inflammations) 01/2022 - 09/2021
2	Neoplasms (Cancer) 10/2021 - 04/2020
2	Wounds and Injuries (Trauma) 11/2020 - 12/2011
2	Blister (Bulla) 11/2020 - 02/2019
2	Atrophy 10/2018 - 06/2017
2	Porokeratosis (Palmoplantar Porokeratosis) 01/2016 - 07/2015
1	Skin Diseases (Skin Disease) 01/2022
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Actinic Keratosis 03/2021
1	Papilloma (Papillomatosis) 03/2021
1	Pathologic Complete Response 03/2021
1	Erythema 12/2020
1	Telangiectasis (Telangiectasia) 12/2020
1	Skin Neoplasms (Skin Cancer) 04/2020
1	Disease Progression 01/2020
1	Alopecia Areata 08/2019
1	Thyroid Diseases (Thyroid Disease) 08/2019
1	Seborrheic Dermatitis 02/2018
1	Infections 09/2016
1	Leukemia 05/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016
1	Port-Wine Stain (Nevus Flammeus) 01/2014
1	Cicatrix (Scar) 08/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2011
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 01/2003

Drug/Important Bio-Agent (IBA)

4	AcidsIBA 12/2018 - 05/2015
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2018 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2019
2	Tranexamic Acid (AMCA)FDA Link 01/2022 - 12/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2011
2	beta-solamarineIBA 01/2022 - 03/2021
2	Mevalonic Acid (Mevalonate)IBA 01/2016 - 07/2015
1	AntioxidantsIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	rhododendrolIBA 10/2021
1	IgA receptor (protein B)IBA 10/2021
1	Glycoproteins (Glycoprotein)IBA 10/2021
1	Therapeutic UsesIBA 03/2021
1	SR-T100IBA 03/2021
1	hydroquinone (Esoterica)FDA Link 12/2020
1	SolutionsIBA 12/2020
1	mussel adhesive proteinIBA 11/2020
1	Biocompatible Materials (Biomaterials)IBA 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	sodium bisulfide (NaHS)IBA 04/2020
1	GasotransmittersIBA 04/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 04/2020
1	ChemokinesIBA 08/2019
1	Interleukin-17 (Interleukin 17)IBA 02/2019
1	EnzymesIBA 02/2019
1	ImmunosorbentsIBA 02/2019
1	Calcineurin InhibitorsIBA 10/2018
1	SteroidsIBA 10/2018
1	pimecrolimus (Elidel)FDA Link 02/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2016
1	CollagenIBA 05/2016
1	MicroRNAs (MicroRNA)IBA 05/2016
1	Insulin (Novolin)FDA Link 05/2016
1	HLA-C Antigens (HLA-C)IBA 01/2016
1	HLA-B Antigens (HLA-B)IBA 01/2016
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2011
1	LigandsIBA 12/2011
1	MethyltransferasesIBA 06/2011
1	DNA (Deoxyribonucleic Acid)IBA 06/2011
1	4-trifluoromethylsalicylic acid (HTB)IBA 01/2003

Therapy/Procedure

4	Photochemotherapy (Photodynamic Therapy) 12/2018 - 05/2015
3	Lasers (Laser) 07/2022 - 01/2003
3	Therapeutics 09/2021 - 09/2015
2	Solid-State Lasers 07/2022 - 01/2003
1	Percutaneous Collagen Induction 12/2020
1	Phototherapy (Light Therapy) 07/2019
1	Rejuvenation 09/2015
1	Dye Lasers 01/2014
1	Laser Therapy (Surgery, Laser) 08/2012
1	Gas Lasers 08/2012